Neurotensin
Overview
Neurotensin is a 13-amino acid neuropeptide widely distributed in the central nervous system and gastrointestinal tract, where it modulates dopaminergic neurotransmission, nociception, and intestinal function. It acts primarily through the neurotensin receptor 1 (NTSR1), influencing mesolimbic and nigrostriatal pathways implicated in motivation, reward, and motor control.
Mechanism of Action
Neurotensin has been studied for its potential roles in schizophrenia, pain modulation, and cognitive function.
Research Summary & Key Findings
Preclinical studies have demonstrated that neurotensin receptor agonists can modulate dopamine release and influence behavioral models of psychosis and cognition, with publications in neuropsychopharmacology journals over the past three decades. Altered neurotensin levels have been observed in postmortem brain tissue from individuals with schizophrenia. No neurotensin-based therapeutics have reached clinical trials due to poor stability and CNS penetration of the native peptide.
Clinical Status
Neurotensin is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.
Administration Routes
References
Primary literature
- PubMed — "Neurotensin"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov — "Neurotensin"
Registered interventional and observational studies, including status and phase.
- PubChem — "Neurotensin"
Chemical structure, molecular properties, and bioactivity data.
Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.
Related Peptides in Cognitive
Semax
FDA ApprovedA synthetic heptapeptide analog of the ACTH(4-7) fragment (Met-Glu-His-Phe-Pro-Gly-Pro) with nootropic and neuroprotecti...
View detailsSelank
InvestigationalA synthetic analog of the endogenous tetrapeptide tuftsin (Thr-Lys-Pro-Arg) with an added Pro-Gly-Pro sequence for stabi...
View detailsCerebrolysin
InvestigationalA porcine brain-derived peptide preparation consisting of low-molecular-weight neuropeptides and free amino acids that m...
View detailsP21 (Peptide)
Research PhaseA small synthetic peptide derived from the active region of ciliary neurotrophic factor (CNTF) designed to promote neuro...
View detailsStart Your Consultation
Get an AI-proposed Neurotensin protocol reviewed by a physician in our network.
Start Your ConsultationFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Neurotensin.
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.